Beam Therapeutics Inc. short interest in 2022
In 2022, Beam Therapeutics Inc.'s disclosed short interest ran from 9.10% of shares outstanding on 14 Jan 2022 to 16.95% on 30 Dec 2022, a change of +7.85 percentage points. The year's high was 18.84% on 15 Jul 2022 and its low 9.10% on 14 Jan 2022, averaging 15.98% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 22.91 days on 30 Nov 2022. Full history: Beam Therapeutics Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 9.10% (14 Jan 2022)
- End of year
- 16.95% (30 Dec 2022)
- Change
- +7.85 pp
- High
- 18.84% (15 Jul 2022)
- Low
- 9.10% (14 Jan 2022)
- Average
- 15.98%
- Highest days to cover
- 22.91 (30 Nov 2022)
- SEC filings marked
- 9
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 9.10% | 6.42 | results (8-K) |
| 31 Jan 2022 | 11.50% | 5.75 | |
| 15 Feb 2022 | 12.06% | 8.69 | |
| 28 Feb 2022 | 12.95% | 11.80 | 10-K filed, results (8-K) |
| 15 Mar 2022 | 12.48% | 8.67 | |
| 31 Mar 2022 | 12.94% | 8.59 | |
| 14 Apr 2022 | 14.35% | 8.75 | |
| 29 Apr 2022 | 15.87% | 9.40 | |
| 13 May 2022 | 16.62% | 6.51 | 10-Q filed, results (8-K) |
| 31 May 2022 | 15.81% | 8.73 | |
| 15 Jun 2022 | 16.53% | 10.17 | |
| 30 Jun 2022 | 18.24% | 7.67 | |
| 15 Jul 2022 | 18.84% | 10.03 | |
| 29 Jul 2022 | 18.46% | 12.58 | |
| 15 Aug 2022 | 17.25% | 8.50 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 17.25% | 9.66 | |
| 15 Sep 2022 | 17.63% | 12.67 | |
| 30 Sep 2022 | 18.65% | 11.31 | |
| 14 Oct 2022 | 18.59% | 18.97 | |
| 31 Oct 2022 | 18.59% | 15.54 | |
| 15 Nov 2022 | 18.47% | 12.07 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 17.66% | 22.91 | |
| 15 Dec 2022 | 16.66% | 14.52 | |
| 30 Dec 2022 | 16.95% | 13.99 |
See also: Beam Therapeutics Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.